Autoimmune hepatitis following mRNA COVID-19 vaccine
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Therapie - 78(2023), 6 vom: 29. Nov., Seite 760-761 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zaiem, Ahmed [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse drug reaction |
|---|
| Anmerkungen: |
Date Completed 13.11.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.therap.2022.12.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362017530 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362017530 | ||
| 003 | DE-627 | ||
| 005 | 20231226090349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.therap.2022.12.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM362017530 | ||
| 035 | |a (NLM)37704459 | ||
| 035 | |a (PII)S0040-5957(23)00109-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zaiem, Ahmed |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autoimmune hepatitis following mRNA COVID-19 vaccine |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Adverse drug reaction | |
| 650 | 4 | |a Adverse effects following immunization | |
| 650 | 4 | |a Autoimmune disease | |
| 650 | 4 | |a COVID-19 vaccine | |
| 650 | 4 | |a Hepatitis | |
| 650 | 4 | |a Pharmacovigilance | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 700 | 1 | |a Ferchichi, Khouloud |e verfasserin |4 aut | |
| 700 | 1 | |a Lakhoua, Ghozlane |e verfasserin |4 aut | |
| 700 | 1 | |a Kaabi, Widd |e verfasserin |4 aut | |
| 700 | 1 | |a Aouinti, Imen |e verfasserin |4 aut | |
| 700 | 1 | |a Rebii Debbiche, Sana |e verfasserin |4 aut | |
| 700 | 1 | |a Kastalli, Sarrah |e verfasserin |4 aut | |
| 700 | 1 | |a Kallel, Lamia |e verfasserin |4 aut | |
| 700 | 1 | |a Charfi, Ons |e verfasserin |4 aut | |
| 700 | 1 | |a El Aidli, Sihem |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapie |d 1947 |g 78(2023), 6 vom: 29. Nov., Seite 760-761 |w (DE-627)NLM000023655 |x 1958-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2023 |g number:6 |g day:29 |g month:11 |g pages:760-761 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.therap.2022.12.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2023 |e 6 |b 29 |c 11 |h 760-761 | ||